Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management

Šutić, Maja; Vukić, Ana; Baranašić, Jurica; Försti, Asta; Džubur, Feđa; Samaržija, Miroslav; Jakopović, Marko; Brčić, Luka; Knežević, Jelena

doi:10.3390/jpm11111102

prikaz prve stranice dokumenta Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management

Download
PDF 9.77 MB

Scientific paper - Review paper

Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management

Journal of Personalized Medicine, 11 (2021), 11; 1102. https://doi.org/10.3390/jpm11111102

Šutić, Maja; Vukić, Ana; Baranašić, Jurica; Försti, Asta; Džubur, Feđa; Samaržija, Miroslav; Jakopović, Marko; Brčić, Luka; Knežević, Jelena

Cite this document

APA 6th Edition

Šutić, M., Vukić, A., Baranašić, J., Försti, A., Džubur, F., Samaržija, M. ... Knežević, J. (2021). Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management. Journal of Personalized Medicine, 11. (11). doi: 10.3390/jpm11111102

MLA 8th Edition

Šutić, Maja, et al. "Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management." Journal of Personalized Medicine, vol. 11, no. 11, 2021. https://doi.org/10.3390/jpm11111102

Chicago 17th Edition

Šutić, Maja, Ana Vukić, Jurica Baranašić, Asta Försti, Feđa Džubur, Miroslav Samaržija, Marko Jakopović, Luka Brčić and Jelena Knežević. "Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management." Journal of Personalized Medicine 11, no. 11 (2021). https://doi.org/10.3390/jpm11111102

Harvard

Šutić, M., et al. (2021) 'Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management', Journal of Personalized Medicine, 11(11). doi: 10.3390/jpm11111102

Vancouver

Šutić M, Vukić A, Baranašić J, Försti A, Džubur F, Samaržija M, and sur.. Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management. Journal of Personalized Medicine [Internet]. 2021 October 27 [cited 2024 November 07];11(11). doi: 10.3390/jpm11111102

IEEE

M. Šutić, et al., "Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management", Journal of Personalized Medicine, vol. 11, no. 11, October 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:314239. [Accessed: 07 November 2024]

Cite this item: https://urn.nsk.hr/urn:nbn:hr:105:314239

Please login to the repository to save this object to your list.

Metadata

Title (english)	Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
Author	Maja Šutić
Author	Ana Vukić
Author	Jurica Baranašić
Author	Asta Försti
Author	Feđa Džubur
Author	Miroslav Samaržija
Author	Marko Jakopović
Author	Luka Brčić
Author	Jelena Knežević
Author's institution	University of Zagreb School of Medicine (Department of Internal Medicine)
Scientific / art field, discipline and subdiscipline	BIOMEDICINE AND HEALTHCARE Clinical Medical Sciences Internal Medicine
Abstract (english)	Lung cancer is the leading cause of cancer-related deaths worldwide. Despite growing efforts for its early detection by screening populations at risk, the majority of lung cancer patients are still diagnosed in an advanced stage. The management of lung cancer has dramatically improved in the last decade and is no longer based on the “one-fits-all” paradigm or the general histological classification of non-small cell versus small cell lung cancer. Emerging options of targeted therapies and immunotherapies have shifted the management of lung cancer to a more personalized treatment approach, significantly influencing the clinical course and outcome of the disease. Molecular biomarkers have emerged as valuable tools in the prognosis and prediction of therapy response. In this review, we discuss the relevant biomarkers used in the clinical management of lung tumors, from diagnosis to prognosis. We also discuss promising new biomarkers, focusing on non-small cell lung cancer as the most abundant type of lung cancer.
Keywords (english)
Language	english
Publication type	Scientific paper - Review paper
Publication status	Published
Peer review	Peer review
Publication version	Published version
Journal title	Journal of Personalized Medicine
Numbering	vol. 11, no. 11, 1102
e-ISSN	2075-4426
DOI	https://doi.org/10.3390/jpm11111102
URN:NBN	urn:nbn:hr:105:314239
Publication	2021-10-27
Document URL	https://www.mdpi.com/2075-4426/11/11/1102
Type of resource	Text
Access conditions	Open access
Terms of use
Created on	2022-03-01 08:49:02